Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax Patients

NCT04411836 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT04411836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax Patients
Lead sponsor
Menzies School of Health Research
Phase
Phase 3
Overall status
Completed
Start date
April 25, 2021
Completion date
September 30, 2024
Enrollment
960 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

malaria relapse, malaria, vivax, plasmodium vivax, vivax malaria